Ascorbic acid enables reversible dopamine receptor 3H-agonist binding
- 4 November 1981
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 29 (20), 2081-2090
- https://doi.org/10.1016/0024-3205(81)90665-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Inhibition of dopamine D-1 and D-2 binding sites in neuronal tissue by ascorbateNeuropharmacology, 1981
- Optimal Conditions for [3H]Apomorphine Binding and Anomalous Equilibrium Binding of [3H]Apomorphine and [3H]Spiperone to Rat Striatal Membranes: Involvement of Surface Phenomena Versus Multiple Binding SitesJournal of Neurochemistry, 1981
- Differentiation by ascorbic acid of dopamine agonist and antagonist binding sites in striatumLife Sciences, 1980
- Stimulation of 3H-apomorphine binding by dopamine and bromocriptineEuropean Journal of Pharmacology, 1980
- Inhibition of dopamine sensitive adenylate cyclase from rat brain striatal homogenates by ascorbic acid1Journal of Neurochemistry, 1977
- The β-adrenergic receptorLife Sciences, 1976
- Selective identification of ‘true’ β‐adrenergic receptors in the plasma membranes of rat adipocytesFEBS Letters, 1975
- Noradrenaline binding and the search for catecholamine receptorsNature, 1974
- A β-Adrenergic Receptor of the Turkey ErythrocytePublished by Elsevier ,1973
- Hormone action at the membrane level III. Epinephrine interaction with the rat liver plasma membraneBiochimica et Biophysica Acta (BBA) - Biomembranes, 1971